1 / 19

TOC - Middle East_Liquid Biopsy Market

In 2021, The Middle East liquid biopsy market was valued at $43.7 million in 2021, and it is expected to reach $175.2 million by 2032, growing at a CAGR of 13.68% during the forecast period 2022-2032.

bisreports
Download Presentation

TOC - Middle East_Liquid Biopsy Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Middle East Liquid Biopsy Market - Country Analysis Table of Content MIDDLE EAST LIQUID BIOPSY MARKET Focus on Product, Technology, Indication, Sample, Workflow, Circulating Biomarker, Usage, and Country Data Analysis and Forecast: 2022-2032 May 2022 All rights reserved at BIS Research Inc. 1

  2. BIS Research is a leading market intelligence and technology research company. BIS Research publishes in- depth market intelligence reports focusing on the market estimations, technology analysis, emerging high- growth applications, deeply segmented granular country-level market data and other important market parameters useful in the strategic decision making for senior management. BIS Research provides multi-client reports, company profiles, databases, and custom research services. MIDDLE EAST LIQUID BIOPSY MARKET Copyright © 2022 BIS Research Inc. All Rights Reserved. This document contains highly confidential information and is the sole property of BIS Research. Disclosing, copying, circulating, quoting or otherwise reproducing any or all contents of this document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people or organization concerned. It may not be accessed by or offered whether for sale or otherwise to any third party. All rights reserved at BIS Research Inc. 2

  3. Table of Content 1 Middle East Liquid Biopsy Market ............................................... 19 1.1 Product Definition ............................................................................................ 20 1.1.1Inclusion and Exclusion ............................................................................. 20 1.1.2Key Questions Answered in the Report .................................................... 21 1.2 Research Methodology ................................................................................... 21 1.2.1Primary Data Sources ................................................................................. 22 1.2.2Source: BIS Research Analysis Secondary Data Sources ...................... 23 1.3 Market Estimation Model ................................................................................. 24 Market Overview ........................................................................ 27 2 2.1 Market Definition .............................................................................................. 28 2.2 Emerging Applications of Liquid Biopsy ....................................................... 28 2.3 Market Footprint and Growth Potential, $Million, 2021-2032 ....................... 29 2.4 COVID-19 Impact on the Middle East Liquid Biopsy Market ........................ 30 3 Industry Insights ........................................................................ 31 3.1 Patent Analysis ................................................................................................ 32 3.1.1Key Players Patent Portfolio ...................................................................... 32 3.1.2Patent Filing Analysis ................................................................................. 33 3.1.3Key Players Patent Expiration Analysis .................................................... 34 3.2 Legal Requirements and Regulations ............................................................ 35 4 Competitive Landscape ............................................................. 37 MIDDLE EAST LIQUID BIOPSY MARKET 4.1 Key Strategies and Developments ................................................................. 38 4.1.1Agreement and Partnership ....................................................................... 39 4.1.2Regulatory Accreditations .......................................................................... 40 4.1.3Product and Service Launches .................................................................. 40 4.1.4Mergers and Acquisitions ........................................................................... 41 4.1.5Approvals ..................................................................................................... 42 Market Dynamics ....................................................................... 44 5 5.1 Market Dynamics ............................................................................................. 45 All rights reserved at BIS Research Inc. 3

  4. 5.1.1Impact Analysis ........................................................................................... 45 5.2 Market Drivers .................................................................................................. 46 5.2.1Liquid Biopsy Demand Inclined by Rising Prevalence of Cancer ........... 46 5.2.2Rise in Patient Preference for Non-Invasive Cancer Diagnosis .............. 47 5.2.3Potential of Liquid Biopsy .......................................................................... 48 5.3 Market Restraints ............................................................................................. 48 5.3.1False Negatives and Positives ................................................................... 48 5.3.2Existing Diagnostic Confidence in Conventional Tissue-Based Diagnosis Practices .................................................................................... 49 5.4 Market Opportunities ....................................................................................... 49 5.4.1Potential Cost Savings ................................................................................ 49 5.4.2Amalgamation of Artificial Intelligence (AI) with Non-Invasive Liquid Biopsy ............................................................................................... 50 Middle East Liquid Biopsy Market, by Product, $Million, 2022 - 2032 .......................................................................................... 51 6 6.1 Overview ........................................................................................................... 52 6.2 Tests/Services .................................................................................................. 53 6.3 Kits and Consumables .................................................................................... 55 6.4 Instruments ...................................................................................................... 56 Middle East Liquid Biopsy Market, by Technology, $Million, 2021 - 2032 ................................................................................ 58 7 7.1 Overview ........................................................................................................... 59 7.2 Polymerase Chain Reaction (PCR) ................................................................. 60 MIDDLE EAST LIQUID BIOPSY MARKET 7.3 Next-Generation Sequencing (NGS) .............................................................. 61 7.4 Fluorescence In-Situ Hybridization (FISH) .................................................... 62 7.5 Other Technologies ......................................................................................... 63 Middle East Liquid Biopsy Market, by Workflow, $Million, 2021 - 2032 ........................................................................................ 65 8 8.1 Overview ........................................................................................................... 66 8.2 Sample Preparation ......................................................................................... 67 8.3 Library Preparation .......................................................................................... 68 All rights reserved at BIS Research Inc. 4

  5. 8.4 Sequencing ...................................................................................................... 69 8.5 Data Analysis ................................................................................................... 70 Middle East Liquid Biopsy Market, by Usage, $Million, 2021 - 2032 .......................................................................................... 71 9 9.1 Overview ........................................................................................................... 72 9.2 Research Use Only (RUO) ............................................................................... 73 9.3 Clinical .............................................................................................................. 74 10Middle East Liquid Biopsy Market, by Sample, $Million, 2021 - 2032 .......................................................................................... 75 10.1Overview ........................................................................................................... 76 10.2Blood ................................................................................................................ 77 10.3Urine ................................................................................................................. 78 10.4Saliva ................................................................................................................ 79 10.5Cerebrospinal Fluid ......................................................................................... 80 11Middle East Liquid Biopsy Market, by Circulating Biomarker, $Million, 2021 - 2032 .................................................................. 81 11.1Overview ........................................................................................................... 82 11.2Circulating Tumor Cells (CTCs) ...................................................................... 83 11.3Cell-Free DNA (cfDNA) .................................................................................... 84 11.4Circulating Cell-Free RNA ............................................................................... 85 11.5Exosomes and Extracellular Vesicles ............................................................ 86 11.6Other Circulating Biomarkers ......................................................................... 87 12Middle East Liquid Biopsy Market, by Indication, $Million, 2021 - 2032 ........................................................................................ 88 MIDDLE EAST LIQUID BIOPSY MARKET 12.1Overview ........................................................................................................... 89 12.2Lung Cancer ..................................................................................................... 90 12.3Breast Cancer .................................................................................................. 91 12.4Prostate Cancer ............................................................................................... 91 12.5Colorectal Cancer ............................................................................................ 92 12.6Melanoma ......................................................................................................... 93 12.7Other Cancers .................................................................................................. 94 All rights reserved at BIS Research Inc. 5

  6. 12.8Non-Oncology Disorder .................................................................................. 94 13Middle East Liquid Biopsy Market, by Clinical Application, $Million, 2021 - 2032 .................................................................. 96 13.1Overview ........................................................................................................... 97 13.2Treatment Monitoring ...................................................................................... 98 13.3Prognosis and Recurrence Monitoring .......................................................... 98 13.4Treatment Selection ........................................................................................ 99 13.5Diagnosis and Screening .............................................................................. 100 14Middle East Liquid Biopsy Market, by Country, $Million, 2021- 2032 ........................................................................................ 102 14.1Overview ......................................................................................................... 103 14.1.1K.S.A. .......................................................................................................... 104 14.1.2Israel ........................................................................................................... 105 14.1.3U.A.E. .......................................................................................................... 106 14.1.4Egypt .......................................................................................................... 107 14.1.5Iran .............................................................................................................. 108 14.1.6Qatar ........................................................................................................... 109 14.1.7Rest-of-the-Middle East ............................................................................ 110 15Market - Competitive Benchmarking & Company Profiles ......... 111 15.1Overview ......................................................................................................... 112 15.2Bio-Rad Laboratories, Inc. ............................................................................ 113 15.2.1Company Overview ................................................................................... 113 MIDDLE EAST LIQUID BIOPSY MARKET 15.2.2Role of Bio-Rad Laboratories, Inc. in the Middle East Liquid Biopsy Market ......................................................................................................... 113 15.2.3Key Competitors of the Company ............................................................ 113 15.2.4Key Customers of the Company .............................................................. 114 15.2.5Financials ................................................................................................... 114 15.2.6Key Insights about Financial Health of the Company ............................ 116 15.2.7SWOT Analysis .......................................................................................... 117 15.3Bioscience Institute S.p.A. ............................................................................ 118 15.3.1Company Overview ................................................................................... 118 All rights reserved at BIS Research Inc. 6

  7. 15.3.2Role of Bioscience Institute S.p.A. in the Middle East Liquid Biopsy Market ......................................................................................................... 118 15.3.3Key Competitors of the Company ............................................................ 118 15.3.4Key Customers of the Company .............................................................. 118 15.3.5SWOT Analysis .......................................................................................... 119 15.4Eurofins Scientific ......................................................................................... 120 15.4.1Company Overview ................................................................................... 120 15.4.2Role of Eurofins Scientific in the Middle East Liquid Biopsy Market ... 120 15.4.3Key Competitors of the Company ............................................................ 120 15.4.4Key Customers of the Company .............................................................. 120 15.4.5Business Strategies .................................................................................. 121 15.4.6Financials ................................................................................................... 121 15.4.7SWOT Analysis .......................................................................................... 123 15.5F. Hoffmann-La Roche Ltd ............................................................................ 124 15.5.1Company Overview ................................................................................... 124 15.5.2Role of F. Hoffmann-La Roche Ltd in the Middle East Liquid Biopsy Market ......................................................................................................... 124 15.5.3Key Competitors of the Company ............................................................ 124 15.5.4Key Customers of the Company .............................................................. 124 15.5.5Business Strategies .................................................................................. 125 15.5.6Financials ................................................................................................... 125 15.5.7Key Insights about Financial Health of the Company ............................ 127 MIDDLE EAST LIQUID BIOPSY MARKET 15.5.8SWOT Analysis .......................................................................................... 128 15.6Guardant Health ............................................................................................. 129 15.6.1Company Overview ................................................................................... 129 15.6.2Role of Guardant Health in the Middle East Liquid Biopsy Market ....... 129 15.6.3Key Competitors of the Company ............................................................ 129 15.6.4Key Customers of the Company .............................................................. 129 15.6.5Business Strategies .................................................................................. 129 15.6.6Financials ................................................................................................... 130 All rights reserved at BIS Research Inc. 7

  8. 15.6.7Key Insights about Financial Health of the Company ............................ 132 15.6.8SWOT Analysis .......................................................................................... 133 15.7Illumina, Inc. ................................................................................................... 134 15.7.1Company Overview ................................................................................... 134 15.7.2Role of Illumina, Inc. in the Middle East Liquid Biopsy Market ............. 134 15.7.3Key Competitors of the Company ............................................................ 134 15.7.4Key Customers of the Company .............................................................. 134 15.7.5Financials ................................................................................................... 135 15.7.6Key Insights about Financial Health of the Company ............................ 137 15.7.7SWOT Analysis .......................................................................................... 138 15.8Natera, Inc. ..................................................................................................... 139 15.8.1Company Overview ................................................................................... 139 15.8.2Role of Natera, Inc. Limited in the Middle East Liquid Biopsy Market .................................................................................................................... 139 15.8.3Key Competitors of the Company ............................................................ 139 15.8.4Key Customers of the Company .............................................................. 139 15.8.5Financials ................................................................................................... 140 15.8.6Key Insights about Financial Health of the Company ............................ 141 15.8.7SWOT Analysis .......................................................................................... 142 15.9NeoGenomics Laboratories, Inc. .................................................................. 143 15.9.1Company Overview ................................................................................... 143 15.9.2Role of NeoGenomics Laboratories, Inc. in the Middle East Liquid Biopsy Market ............................................................................................ 143 MIDDLE EAST LIQUID BIOPSY MARKET 15.9.3Key Competitors of the Company ............................................................ 143 15.9.4Key Customers of the Company .............................................................. 143 15.9.5Corporate Strategies ................................................................................. 144 15.9.6Financials ................................................................................................... 144 15.9.7Key Insights about Financial Health of the Company ............................ 146 15.9.8SWOT Analysis .......................................................................................... 147 15.10PerkinElmer Inc. ............................................................................................. 148 All rights reserved at BIS Research Inc. 8

  9. 15.10.1 Company Overview ............................................................................. 148 15.10.2 Role of PerkinElmer Inc. in the Middle East Liquid Biopsy Market ......................................................................................................... 148 15.10.3 Key Competitors of the Company ..................................................... 148 15.10.4 Key Customers of the Company ........................................................ 148 15.10.5 Financials ............................................................................................ 149 15.10.6 Key Insights about Financial Health of the Company ...................... 151 15.10.7 SWOT Analysis .................................................................................... 152 15.11QIAGEN N.V. ................................................................................................... 153 15.11.1 Company Overview ............................................................................. 153 15.11.2 Role of QIAGEN N.V. in the Middle East Liquid Biopsy Market ...... 153 15.11.3 Key Competitors of the Company ..................................................... 153 15.11.4 Key Customers of the Company ........................................................ 153 15.11.5 Financials ............................................................................................ 154 15.11.6 Key Insights about Financial Health of the Company ...................... 156 15.11.7 SWOT Analysis .................................................................................... 157 15.12Sysmex Corporation ...................................................................................... 158 15.12.1 Company Overview ............................................................................. 158 15.12.2 Role of Sysmex Corporation in the Middle East Liquid Biopsy Testing Market ........................................................................................... 158 15.12.3 Key Competitors of the Company ..................................................... 158 15.12.4 Key Customers of the Company ........................................................ 158 MIDDLE EAST LIQUID BIOPSY MARKET 15.12.5 Business Strategies ............................................................................ 159 15.12.6 Financials ............................................................................................ 159 15.12.7 Key Insights about Financial Health of the Company ...................... 160 15.12.8 SWOT Analysis .................................................................................... 161 15.13Thermo Fisher Scientific Inc. ........................................................................ 162 15.13.1 Company Overview ............................................................................. 162 15.13.2 Role of Thermo Fisher Scientific Inc. in the Middle East Liquid Biopsy Market ............................................................................................ 162 15.13.3 Key Competitors of the Company ..................................................... 163 All rights reserved at BIS Research Inc. 9

  10. 15.13.4 Key Customers of the Company ........................................................ 163 15.13.5 Financials ............................................................................................ 164 15.13.6 Key Insights about Financial Health of the Company ...................... 166 15.13.7 SWOT Analysis .................................................................................... 167 MIDDLE EAST LIQUID BIOPSY MARKET All rights reserved at BIS Research Inc. 10

  11. List of Figures Figure 1: Middle East Cancer Burden, 2020 Figure 2: Middle East Liquid Biopsy Market Segmentation Figure 3: Middle East Liquid Biopsy Market: Research Methodology Figure 4: Primary Research Methodology Figure 5: Bottom-Up Approach (Segment-Wise Analysis) Figure 6: Top-Down Approach (Segment-Wise Analysis) Figure 7: Middle East Liquid Biopsy Market, $Million, 2021-2032 Figure 8: Share of Patents Filed in the Middle East Liquid Biopsy Market, FY2014-FY2018 Figure 9: Liquid Biopsy Patent Analysis, FY2014-FY2018 Figure 10: : Patent Expiration Analysis Figure 11: Role of FDA in Advancing Liquid Biopsy Figure 12: Share of Key Developments and Strategies, January 2017-January 2019 Figure 13: Share (by Company), January 2017-January 2019 Figure 14: Share of Regulatory Accreditations (by Company), January 2017-January 2019 Figure 15: Share of Product and Service Launches (by Company), January 2017-January 2019 Figure 16: Share of Mergers and Acquisitions (by Company), January 2017-January 2019 Figure 17: Approvals (by Company), January 2017-January 2019 Figure 18: Middle East Liquid Biopsy Market Dynamics Figure 19: Middle East Cancer Burden, 2020 Figure 20: Middle East Liquid Biopsy Market Segmentation (by Product) Figure 21: Share of Middle East Liquid Biopsy Market (by Product), $Million, 2021 and 2032 Figure 22: Middle East Liquid Biopsy Market (Tests/Services), $Million, 2021-2032 MIDDLE EAST LIQUID BIOPSY MARKET Figure 23: Middle East Liquid Biopsy Market (Kits and Consumables), $Million, 2021-2032 Figure 24: Middle East Liquid Biopsy Market (Instruments), $Million, 2021-2032 Figure 25: Middle East Liquid Biopsy Market (by Technology) Figure 26: Middle East Liquid Biopsy Market (by Technology), $Million, 2021 and 2032 Figure 27: Middle East Liquid Biopsy Market (Polymerase Chain Reaction (PCR)), $Million, 2021-2032 Figure 28: Middle East Liquid Biopsy Market (Next-Generation Sequencing (NGS)), $Million, 2021-2032 Figure 29: Middle East Liquid Biopsy Market (Fluorescence In-Situ Hybridization (FISH)), $Million, 2021- 2032 Figure 30: Middle East Liquid Biopsy Market (Other Technologies), $Million, 2021-2032 All rights reserved at BIS Research Inc. 11

  12. Figure 31: Middle East Liquid Biopsy Market (by Workflow) Figure 32: Middle East Liquid Biopsy Market (by Workflow), $Million, 2021 and 2032 Figure 33: Middle East Liquid Biopsy Market (Sample Preparation), $Million, 2021-2032 Figure 34: Middle East Liquid Biopsy Market (Library Preparation), $Million, 2021-2032 Figure 35: Middle East Liquid Biopsy Market (Sequencing), $Million, 2021-2032 Figure 36: Middle East Liquid Biopsy Market (Data Analysis), $Million, 2021-2032 Figure 37: Middle East Liquid Biopsy Market (by Usage) Figure 38: Middle East Liquid Biopsy Market (by Usage), $Million, 2021 and 2032 Figure 39: Middle East Liquid Biopsy Market (Research Use Only (RUO)), $Million, 2021-2032 Figure 40: Middle East Liquid Biopsy Market (Clinical), $Million, 2021-2032 Figure 41: Middle East Liquid Biopsy Market (by Sample) Figure 42: Middle East Liquid Biopsy Market (by Sample), $Million, 2021 and 2032 Figure 43: Middle East Liquid Biopsy Market (Blood), $Million, 2021-2032 Figure 44: Middle East Liquid Biopsy Market (Urine), $Million, 2021-2032 Figure 45: Middle East Liquid Biopsy Market (Saliva), $Million, 2021-2032 Figure 46: Middle East Liquid Biopsy Market (Cerebrospinal Fluid), $Million, 2021-2032 Figure 47: Middle East Liquid Biopsy Market (by Circulating Biomarker) Figure 48: Middle East Liquid Biopsy Market (by Circulating Biomarker), $Million, 2021 and 2032 Figure 49: Middle East Liquid Biopsy Market (Circulating Tumor Cells (CTCs)), $Million, 2021-2032 Figure 50: Middle East Liquid Biopsy Market (Cell-Free DNA (cfDNA)), $Million, 2021-2032 Figure 51: Middle East Liquid Biopsy Market (Circulating Cell-Free RNA), $Million, 2021-2032 Figure 52: Middle East Liquid Biopsy Market (Exosomes and Extracellular Vesicles), $Million, 2021-2032 Figure 53: Middle East Liquid Biopsy Market (Other Circulating Biomarkers), $Million, 2021-2032 Figure 54: Middle East Liquid Biopsy Market (by Indication) MIDDLE EAST LIQUID BIOPSY MARKET Figure 55: Middle East Liquid Biopsy Market (by Indication), $Million, 2021 and 2032 Figure 56: Middle East Liquid Biopsy Market (Lung Cancer), $Million, 2021-2032 Figure 57: Middle East Liquid Biopsy Market (Breast Cancer), $Million, 2021-2032 Figure 58: Middle East Liquid Biopsy Market (Prostate Cancer), $Million, 2021-2032 Figure 59: Middle East Liquid Biopsy Market (Colorectal Cancer), $Million, 2021-2032 Figure 60: Middle East Liquid Biopsy Market (Melanoma), $Million, 2021-2032 Figure 61: Middle East Liquid Biopsy Market (Other Cancers), $Million, 2021-2032 Figure 62: Middle East Liquid Biopsy Market (Non-Oncology Disorder), $Million, 2021-2032 Figure 63: Middle East Liquid Biopsy Market (by Clinical Application) All rights reserved at BIS Research Inc. 12

  13. Figure 64: Middle East Liquid Biopsy Market (by Clinical Application), $Million, 2021 and 2032 Figure 65: Middle East Liquid Biopsy Market (Treatment Monitoring), $Million, 2021-2032 Figure 66: Middle East Liquid Biopsy Market (Prognosis and Recurrence Monitoring), $Million, 2021- 2032 Figure 67: Middle East Liquid Biopsy Market (Treatment Selection), $Million, 2021-2032 Figure 68: Middle East Liquid Biopsy Market (Diagnosis and Screening), $Million, 2021-2032 Figure 69: Middle East Liquid Biopsy Market (by Country), $Million, 2021-2032 Figure 70: Middle East Liquid Biopsy Market (by Country), $Million, 2021 and 2032 Figure 71: K.S.A. Liquid Biopsy Market, $Million, 2021-2032 Figure 72: Israel Liquid Biopsy Market, $Million, 2021-2032 Figure 73: U.A.E. Liquid Biopsy Market, $Million, 2021-2032 Figure 74: Egypt Liquid Biopsy Market, $Million, 2021-2032 Figure 75: Iran East Liquid Biopsy Market, $Million, 2021-2032 Figure 76: Qatar Middle East Liquid Biopsy Market, $Million, 2021-2032 Figure 77: Rest-of-the-Middle East Liquid Biopsy Market, $Million, 2021-2032 Figure 78: Total Number of Companies Profiled Figure 79: Bio-Rad Laboratories, Inc.: Overall Product Portfolio Figure 80: Bio-Rad Laboratories, Inc.: Overall Financials, $Million, 2019-2021 Figure 81: Bio-Rad Laboratories, Inc.: Revenue (by Segment), $Million, 2019-2021 Figure 82: Bio-Rad Laboratories, Inc.: Revenue (by Region), $Million, 2019-2021 Figure 83: Bio-Rad Laboratories, Inc.: R&D Expenditure, $Million, 2019-2021 Figure 84: Bio-Rad Laboratories, Inc.: SWOT Analysis Figure 85: Bioscience Institute S.p.A.: Overall Product Portfolio Figure 86: Bioscience Institute S.p.A.: SWOT Analysis MIDDLE EAST LIQUID BIOPSY MARKET Figure 87: Eurofins Scientific: Overall Product Portfolio Figure 88: Eurofins Scientific: Overall Financials, $Million, 2019-2021 Figure 89: Eurofins Scientific: Revenue (by Region), $Million, 2019-2021 Figure 90: Eurofins Scientific: SWOT Analysis Figure 91: F. Hoffmann-La Roche Ltd: Overall Product Portfolio Figure 92: F. Hoffmann-La Roche Ltd: Overall Financials, $Million, 2019-2021 Figure 93: F. Hoffmann-La Roche Ltd: Revenue (by Segment), $Million, 2019-2021 Figure 94: F. Hoffmann-La Roche Ltd: Revenue (by Region), $Million, 2019-2021 Figure 95: F. Hoffmann-La Roche Ltd: R&D Expenditure, $Million, 2019-2021 All rights reserved at BIS Research Inc. 13

  14. Figure 96: F. Hoffmann-La Roche Ltd: SWOT Analysis Figure 97: Guardant Health: Overall Product Portfolio Figure 98: Guardant Health: Overall Financials, $Million, 2019-2021 Figure 99: Guardant Health: Revenue (by Segment), $Million, 2019-2021 Figure 100: Guardant Health: Revenue (by Region), $Million, 2019-2021 Figure 101: Guardant Health: R&D Expenditure, $Million, 2019-2021 Figure 102: Guardant Health.: SWOT Analysis Figure 103: Illumina, Inc.: Overall Product Portfolio Figure 104: Illumina, Inc.: Overall Financials, $Million, 2019-2021 Figure 105: Illumina, Inc.: Revenue (by Segment), $Million, 2019-2021 Figure 106: Illumina, Inc.: Revenue (by Region), $Million, 2019-2021 Figure 107: Illumina, Inc.: R&D Expenditure, $Million, 2019-2021 Figure 108: Illumina, Inc.: SWOT Analysis Figure 109: Natera, Inc.: Overall Product Portfolio Figure 110: Natera, Inc.: Overall Financials, $Million, 2019-2021 Figure 111: Natera, Inc.: Revenue (by Segment), $Million 2019-2021 Figure 112: Natera, Inc.: R&D Expenditure, $Million, 2019-2021 Figure 113: Natera, Inc.: SWOT Analysis Figure 114: NeoGenomics Laboratories, Inc.: Overall Product Portfolio Figure 115: NeoGenomics Laboratories, Inc.: Overall Financials, $Million, 2019-2021 Figure 116: NeoGenomics Laboratories, Inc.: Revenue (by Segment), $Million, 2019-2021 Figure 117: NeoGenomics Laboratories, Inc.: R&D Expenditure, $Million, 2019-2021 Figure 118: NeoGenomics Laboratories, Inc.: SWOT Analysis Figure 119: PerkinElmer Inc.: Overall Product Portfolio MIDDLE EAST LIQUID BIOPSY MARKET Figure 120: PerkinElmer Inc.: Overall Financials, $Million, 2019-2021 Figure 121: PerkinElmer Inc.: Revenue (by Segment), $Million, 2019-2021 Figure 122: PerkinElmer, Inc.: Revenue (by Region), $Million, 2019-2021 Figure 123: PerkinElmer, Inc.: R&D Expenditure, $Million, 2019-2021 Figure 124: PerkinElmer, Inc.: SWOT Analysis Figure 125: QIAGEN N.V.: Overall Product Portfolio Figure 126: QIAGEN N.V.: Overall Financials, $Million, 2019-2021 Figure 127: QIAGEN N.V.: Revenue (by Segment), $Million, 2019-2021 Figure 128: QIAGEN N.V.: Revenue (by Region), $Million, 2019-2021 All rights reserved at BIS Research Inc. 14

  15. Figure 129: QIAGEN N.V.: R&D Expenditure, $Million, 2019-2021 Figure 130: QIAGEN N.V. N.V.: SWOT Analysis Figure 131: Sysmex Corporation: Overall Product Portfolio Figure 132: Sysmex Corporation: Overall Financials, $Million, 2018-2020 Figure 133: Sysmex Corporation: Revenue (by Region), $Million, 2018-2020 Figure 134: Sysmex Corporation: R&D Expenditure, $Million, 2018-2020 Figure 135: Sysmex Corporation: SWOT Analysis Figure 136: Thermo Fisher Scientific Inc.: Overall Product Portfolio Figure 137: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2019-2021 Figure 138: Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2019-2021 Figure 139: Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2019-2021 Figure 140: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2019-2021 Figure 141: Thermo Fisher Scientific Inc.: SWOT Analysis MIDDLE EAST LIQUID BIOPSY MARKET All rights reserved at BIS Research Inc. 15

  16. List of Tables Table 1: Middle East Liquid Biopsy Market: Key Players Patent Portfolio Table 2: Key Players of Liquid Biopsy (Cost Savings) Table 3: Companies Providing Tests/Services Table 4: Companies Providing Kits and Consumables Table 5: Companies Providing Instruments MIDDLE EAST LIQUID BIOPSY MARKET All rights reserved at BIS Research Inc. 16

  17. BIS Research Offerings: We are on a mission to harness the potential of disruptive technologies to make businesses thrive in today’s digital age. We have the vision to be a leading and preferred knowledge partner for corporates and institutions worldwide and assist them with market intelligence in the area of emerging technologies, advisories, and other innovative solutions. Know More Know More Know More MIDDLE EAST LIQUID BIOPSY MARKET Know More All rights reserved at BIS Research Inc. 17

  18. Disclaimer BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth. This document and its contents are confidential and may not be further distributed, published, or reproduced, in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly through incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce Information in legal proceedings. Market reports are based on expectations, estimates, and projections as of the date such information is available. Any recommendation contained in this report may not be suitable for all investors or businesses. The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to market fluctuations and business, economic and competitive uncertainties and contingencies. For more details regarding permission, please contact us: Email: sales@bisresearch.com Tel: +1 510 404 8135 MIDDLE EAST LIQUID BIOPSY MARKET All rights reserved at BIS Research Inc. 18

  19. BIS RESEARCH INC. MIDDLE EAST LIQUID BIOPSY MARKET 39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686 E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135 Global Delivery Center Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway, Sector 126, Noida, U.P., 201303, India Tel: +91 120 4261540 / 4261544 www.bisresearch.com All rights reserved at BIS Research Inc. 19

More Related